Shanghai Serum Bio-Technology Co., Ltd.SSE: 688163

Announcement on Convening Q3 2024 Performance Briefing

Oct 22, 2024 · Issued by Shanghai Serum Bio-Technology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 22, 2024

On 6ix: 6ix.com/news/announcement-on-convening-q3-2024-performance-briefing-19

Announcement on Convening Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Serum Bio-Technology Co., Ltd. on 6ix

Earlier from Shanghai Serum Bio-Technology

Announcement on Resolution of the 1st Extraordinary General Meeting in 2024Oct 1, 2024
Announcement on Convening 2024 Semi-annual Performance and Cash Dividend BriefingSep 19, 2024
Notice on Convening the 1st Extraordinary General Meeting in 2024Sep 14, 2024
Announcement on Implementation of Dividend Distribution for Half Year of 2024Sep 6, 2024
Announcement on the 2024 Semi-annual Profit Distribution PlanAug 28, 2024

Later from Shanghai Serum Bio-Technology

Report for Q3 2024Oct 26, 2024
Announcement on Provision for Impairment of Long-term Equity InvestmentNov 23, 2024
Announcement on Change of Chief Financial OfficerFeb 8, 2025
Announcement on Preliminary Earnings Estimate for 2024Feb 26, 2025
Announcement on Using Some Temporarily Idle Raised Funds for Cash ManagementMar 21, 2025

All Shanghai Serum Bio-Technology news releases

Follow Shanghai Serum Bio-Technology into a list and get an email when it puts out news.

Follow Shanghai Serum Bio-Technology